Identification of Cys140 in Helix 4 As an Exofacial Cysteine Residue Within the Substrate-translocation Channel of Rat Equilibrative Nitrobenzylthioinosine (NBMPR)-insensitive Nucleoside Transporter RENT2

Overview

Journal Biochem J

Specialty Biochemistry

Date 2001 Jan 5

PMID 11139404

Citations 17

Authors

S Y Yao

M Sundaram

E G Chomey

C E Cass

S A Baldwin

J D Young

Affiliations

Soon will be listed here.

Abstract

The human and rat equilibrative nucleoside transporter proteins hENT1, rENT1, hENT2 and rENT2 belong to a family of integral membrane proteins with 11 potential transmembrane segments (TMs), and are distinguished functionally by differences in transport of nucleobases and sensitivity to inhibition by nitrobenzylthioinosine (NBMPR) and vasoactive drugs. In the present study, we have produced recombinant hENT1, rENT1, hENT2 and rENT2 in Xenopus oocytes and investigated uridine transport following exposure to the impermeant thiol-reactive reagent p-chloromercuriphenyl sulphonate (PCMBS). PCMBS caused reversible inhibition of uridine influx by rENT2, but had no effect on hENT1, hENT2 or rENT1. This difference correlated with the presence in rENT2 of a unique Cys residue (Cys(140)) in the outer half of TM4 that was absent from the other ENTs. Mutation of Cys(140) to Ser produced a functional protein (rENT2/C140S) that was insensitive to inhibition by PCMBS, identifying Cys(140) as the exofacial Cys residue in rENT2 responsible for PCMBS inhibition. Uridine protected wild-type rENT2 against PCMBS inhibition, suggesting that Cys(140) in TM4 lies within or is closely adjacent to the substrate-translocation channel of the transporter. TM4 has been shown previously to be within a structural domain (TMs 3-6) responsible for interactions with NBMPR, vasoactive drugs and nucleobases.

Citing Articles

Equilibrative Nucleoside Transporter 2: Properties and Physiological Roles.

Naes S, Ab-Rahim S, Mazlan M, Abdul Rahman A Biomed Res Int. 2020; 2020:5197626.

PMID: 33344638 PMC: 7732376. DOI: 10.1155/2020/5197626.

Substituted cysteine accessibility method (SCAM) analysis of the transport domain of human concentrative nucleoside transporter 3 (hCNT3) and other family members reveals features of structural and functional importance.

Mulinta R, Yao S, Ng A, Cass C, Young J J Biol Chem. 2017; 292(23):9505-9522.

PMID: 28385889 PMC: 5465479. DOI: 10.1074/jbc.M116.743997.

Identification of Key Residues for Urate Specific Transport in Human Glucose Transporter 9 (hSLC2A9).

Long W, Panigrahi R, Panwar P, Wong K, O Neill D, Chen X Sci Rep. 2017; 7:41167.

PMID: 28117388 PMC: 5259734. DOI: 10.1038/srep41167.

Functional characterization of human equilibrative nucleoside transporter 1.

Huang W, Zeng X, Shi Y, Liu M Protein Cell. 2016; 8(4):284-295.

PMID: 27995448 PMC: 5359181. DOI: 10.1007/s13238-016-0350-x.

Equilibrative nucleoside transporters-A review.

Boswell-Casteel R, Hays F Nucleosides Nucleotides Nucleic Acids. 2016; 36(1):7-30.

PMID: 27759477 PMC: 5728162. DOI: 10.1080/15257770.2016.1210805.

References

Kwong F, Fincham H, Davies A, Beaumont N, Henderson P, Young J . Mammalian nitrobenzylthioinosine-sensitive nucleoside transport proteins. Immunological evidence that transporters differing in size and inhibitor specificity share sequence homology. J Biol Chem. 1992; 267(30):21954-60. View

VICKERS M, Mani R, Sundaram M, Hogue D, Young J, Baldwin S . Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative.... Biochem J. 1999; 339 ( Pt 1):21-32. PMC: 1220123. View

Kwong F, Wu J, Shi M, Fincham H, Davies A, Henderson P . Enzymic cleavage as a probe of the molecular structures of mammalian equilibrative nucleoside transporters. J Biol Chem. 1993; 268(29):22127-34. View

Sundaram M, Yao S, Ng A, Griffiths M, Cass C, Baldwin S . Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. J Biol Chem. 1998; 273(34):21519-25. DOI: 10.1074/jbc.273.34.21519. View

Jarvis S . Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole. Mol Pharmacol. 1986; 30(6):659-65. View

Ritzel M, Yao S, Ng A, Mackey J, Cass C, Young J . Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. Mol Membr Biol. 1999; 15(4):203-11. DOI: 10.3109/09687689709044322. View

Tse C, Wu J, Young J . Evidence for the asymmetrical binding of p-chloromercuriphenyl sulphonate to the human erythrocyte nucleoside transporter. Biochim Biophys Acta. 1985; 818(3):316-24. DOI: 10.1016/0005-2736(85)90005-7. View

Shryock J, Belardinelli L . Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol. 1997; 79(12A):2-10. DOI: 10.1016/s0002-9149(97)00256-7. View

Baldwin S, Mackey J, Cass C, Young J . Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today. 1999; 5(5):216-24. DOI: 10.1016/S1357-4310(99)01459-8. View

10.

Jarvis S, McBride D, Young J . Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites. J Physiol. 1982; 324:31-46. PMC: 1250692. DOI: 10.1113/jphysiol.1982.sp014099. View

11.

Fredholm B . Adenosine and neuroprotection. Int Rev Neurobiol. 1997; 40:259-80. View

12.

Wang J, Su S, Dresser M, Schaner M, Washington C, Giacomini K . Na(+)-dependent purine nucleoside transporter from human kidney: cloning and functional characterization. Am J Physiol. 1998; 273(6):F1058-65. DOI: 10.1152/ajprenal.1997.273.6.F1058. View

13.

Jarvis S, Young J . Nucleoside translocation in sheep reticulocytes and fetal erythrocytes: a proposed model for the nucleoside transporter. J Physiol. 1982; 324:47-66. PMC: 1250693. DOI: 10.1113/jphysiol.1982.sp014100. View

14.

Yao S, Ng A, Muzyka W, Griffiths M, Cass C, Baldwin S . Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem. 1997; 272(45):28423-30. DOI: 10.1074/jbc.272.45.28423. View

15.

Griffiths M, Beaumont N, Yao S, Sundaram M, Boumah C, Davies A . Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat Med. 1997; 3(1):89-93. DOI: 10.1038/nm0197-89. View

16.

Jarvis S, Young J . Nucleoside transport in rat erythrocytes: two components with differences in sensitivity to inhibition by nitrobenzylthioinosine and p-chloromercuriphenyl sulfonate. J Membr Biol. 1986; 93(1):1-10. DOI: 10.1007/BF01871013. View

17.

Sarkar G, Sommer S . The "megaprimer" method of site-directed mutagenesis. Biotechniques. 1990; 8(4):404-7. View

18.

Che M, Ortiz D, Arias I . Primary structure and functional expression of a cDNA encoding the bile canalicular, purine-specific Na(+)-nucleoside cotransporter. J Biol Chem. 1995; 270(23):13596-9. DOI: 10.1074/jbc.270.23.13596. View

19.

Griffiths M, Yao S, Abidi F, Phillips S, Cass C, Young J . Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem J. 1998; 328 ( Pt 3):739-43. PMC: 1218980. DOI: 10.1042/bj3280739. View

20.

Huang Q, Yao S, Ritzel M, Paterson A, Cass C, Young J . Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J Biol Chem. 1994; 269(27):17757-60. View